H.R.733 - Pancreatic Cancer Research and Education Act

To amend the Public Health Service Act to provide for a Pancreatic Cancer Initiative, and for other purposes. view all titles (5)

All Bill Titles

  • Official: To amend the Public Health Service Act to provide for a Pancreatic Cancer Initiative, and for other purposes. as introduced.
  • Short: Pancreatic Cancer Research and Education Act as introduced.
  • Official: To provide for scientific frameworks with respect to recalcitrant cancers. as amended by house.
  • Official: Pancreatic Cancer Research and Education Act as introduced.
  • Short: Recalcitrant Cancer Research Act of 2012 as passed house.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 11
  • All-Time: 4,010
 
Introduced
 
House
Passed
 
Senate
Passes
 
President
Signs
 

 
02/16/11
 
09/19/12
 
 
 
 
 

Sponsor

Representative

Anna Eshoo

D-CA

View Co-Sponsors (294)

Official Summary

Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1)

Official Summary

Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes:
(1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research;
(2) identification of research questions that have not been adequately addressed; and
(3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions. Requires the Director to develop the framework within 18 months and review and update it every 5 years. Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer. Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act. Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.

...Read the Rest


Latest Letters to Congress

See All Letters (3)
 


Vote on This Bill

100% Users Support Bill

4 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC